Skip to main content

Reporter May 11 2012

Long live the therapeutic stem cells

May. 17, 2012—Enhancing stem cell survival is key to improving cell-based therapies for regenerative medicine, and a new drug could help.

Read more


New clue to ADHD

May. 15, 2012—A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD.

Read more


Perfect timing for sensory processing

May. 11, 2012—Identification of brain regions involved in processing sights and sounds may offer insights into disorders like autism and dyslexia.

Read more


Probing epilepsy’s molecular sparks

May. 10, 2012—Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more